NTR

Key Factors to Evaluate Before Investing in Nutrien (NTR)

It hasn't been a great morning session for Nutrien investors, who have watched their shares sink by -1.3% to a price of $47.68. Some of you might be wondering if it's time to buy the dip. If you are considering this, make sure to check the company's fundamentals first to determine if the shares are fairly valued at today's prices.

Nutrien's Earnings and Assets May Be Undervalued:

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The company belongs to the Industrials sector, which has an average price to earnings (P/E) ratio of 25.42 and an average price to book (P/B) ratio of 3.2. In contrast, Nutrien has a trailing 12 month P/E ratio of 29.8 and a P/B ratio of 0.94.

When we divide Nutrien's P/E ratio by its expected EPS growth rate of the next five years, we obtain its PEG ratio of -0.57. Since it's negative, the company has negative growth expectations, and most investors will probably avoid the stock unless it has an exceptionally low P/E and P/B ratio.

Generally Positive Cash Flows but a Declining EPS Growth Trend:

2018 2019 2020 2021 2022 2023
Revenue (M) $19,636 $20,084 $20,908 $27,712 $37,884 $29,056
Gross Margins 27% 27% 25% 34% 41% 28%
Net Margins 18% 5% 2% 11% 20% 4%
Net Income (M) $3,573 $992 $459 $3,179 $7,687 $1,282
Earnings Per Share $5.72 $1.7 $0.81 $5.52 $14.18 $2.53
EPS Growth n/a -70.28% -52.35% 581.48% 156.88% -82.16%
Free Cash Flow (M) $2,052 $3,665 $3,323 $3,886 $8,110 $5,066
Total Debt (M) $7,579 $8,553 $10,047 $7,521 $8,040 $8,913
Net Debt / EBITDA 2.62 2.15 2.97 1.04 0.56 1.62
Current Ratio 1.4 1.17 1.35 1.11 1.14 1.17
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS